Status:
COMPLETED
Lithium Cannabis Withdrawal Study
Lead Sponsor:
Sydney South West Area Health Service
Collaborating Sponsors:
The University of New South Wales
Conditions:
Cannabis Dependence
Substance Withdrawal Syndrome
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
This trial will examine the efficacy of lithium in providing symptomatic relief from the withdrawal discomfort experienced by some dependent users of cannabis on cessation of regular use. Significant ...
Detailed Description
There are currently no accepted pharmacotherapies for the management of cannabis withdrawal. A recent study by Cui et al (2001) investigated the effects and mechanism of lithium on cannabinoid withdra...
Eligibility Criteria
Inclusion
- DSM-IV diagnosis of cannabis dependence with at least a three-month history.
- Seeking treatment for primary cannabis problem
- Withdrawal identified as barrier to abstinence
Exclusion
- Other drug dependency (excluding nicotine)
- Client is breastfeeding or pregnant.
- Client has contraindicated medical or psychiatric conditions.
- Client currently taking other medications that may interact with lithium.
- Known hypersensitivity / side effects with Lithium.
- Currently receiving Lithium from another source.
- Currently prescribed any antidepressant / mood stabilising / antipsychotic medication.
- Currently receiving opioid pharmacotherapy.
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2006
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00114439
Start Date
September 1 2005
End Date
September 1 2006
Last Update
September 27 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Corella Drug Treatment Service
Fairfield, New South Wales, Australia, 2176